首页|期刊导航|时珍国医国药|宣痹泻黄汤治疗急性胰腺炎肺损伤的真实世界研究

宣痹泻黄汤治疗急性胰腺炎肺损伤的真实世界研究OA

Real-world study on Xuanbi Xiehuang Decoction(宣痹泻黄汤)in the treatment of acute pan-creatitis with lung injury

中文摘要英文摘要

目的 通过真实世界临床研究,观察宣痹泻黄汤治疗急性胰腺炎肺损伤(AP-ALI)患者的有效性.方法 总共纳入56例AP-ALI患者,其中观察组38例,对照组为18例.对照组仅采用标准西医治疗方案,观察组在接受西医治疗基础上增加宣痹泻黄汤治疗,疗程均为7d.比较两组治疗前后的综合疗效、中医证候总积分、血清WBC、CRP、IL-6及PCT、AMY、LPS水平、改良Marshall评分、APACHE-Ⅱ评分、PaO2、PaO2/FiO2、乳酸等情况.结果 经治疗后,中医证候疗效显示观察组的愈显率(71.05%)高于对照组(33.33%)(P<0.05),疾病综合疗效判定显示观察组的愈显率(76.32%)高于对照组(55.56%)(P<0.05),观察组中医证候总积分显著低于对照组(P<0.001);两组患者血清WBC、CRP、IL-6、PCT、AMY、LPS水平较治疗前均有下降(P<0.001),且观察组明显优于对照组(P<0.05或P<0.001);改良Marshall评分与APACHE-Ⅱ评分均较治疗前明显降低(P<0.05或P<0.001),且观察组的降幅更为显著(P<0.001);两组患者PaO2/FiO2均呈显著上升趋势(P<0.001),观察组优于对照组(P<0.001);观察组患者PaO2较治疗前显著升高(P<0.001),而对照组PaO2较治疗前无显著差异(P>0.05);两组患者的乳酸水平较治疗前均呈降低态势(P<0.01或P<0.001),且观察组下降更显著(P<0.001).结论 宣痹泻黄汤能够显著改善AP-ALI患者临床症状,显著下调血液炎性因子及相关酶类水平,同时增强胰腺生理机能,提升血氧饱和度指数,促进肺功能恢复,其整体治疗效果优于常规西医治疗.

Objective To observe the efficacy of Xuanbi Xiehuang Decoction(宣痹泻黄汤,XBXHD)in the treatment of patients with acute pancreatitiswith lung injury(AP-ALI)through real-world clinical research.Methods A total of 56 patients with AP-ALI were included,among which 38 cases were in the observation group and 18 cases were in the control group.The control group only received the standard Western medical treatment plan,while the observation group was treated with XBXHD on the basis of Western medical treatment.The treatment course for both groups was 7 days.The comprehensive therapeutic effects,total scores of TCM syndromes,levels of serum WBC,CRP,IL-6,PCT,AMY,LPS,modified Marshall score,APACHE-II score,PaO2,PaO2/FiO2,lactic acid,etc.before and after treatment were compared between the two groups.Results After treatment,the therapeutic effect of traditional Chinese medicine syndromes showed that the cure rate of the observation group(71.05%)was higher than that of the control group(33.33%)(P<0.5),and the comprehensive therapeutic effect determination of the disease showed that the cure rate of the observation group(76.32%)was higher than that of the control group(55.56%)(P<0.5),The total score of TCM syndromes in the observation group was significantly lower than that in the control group(P<0.001).The levels of serum WBC,CRP,IL-6,PCT,AMY and LPS in both groups of patients decreased compared with those before treatment(P<0.001),and the observation group was significantly better than the control group(P<0.05 or P<0.001).Both the modified Marshall score and the APACHE-II score were significantly lower than those before treatment(P<0.05 or P<0.001),and the decrease in the observation group was more significant(P<0.001).Both groups of patients showed a significant upward trend in PaO2/FiO2(P<0.001),and the observation group was better than the control group(P<0.001).The PaO2 of patients in the observation group was significantly increased compared with that before treatment(P<0.001),while there was no significant difference in PaO2 of the control group compared with that before treatment(P>0.05).The lactic acid levels of both groups of patients showed a decreasing trend compared with those before treatment(P<0.01 or P<0.001),and the decrease in the observation group was more significant(P<0.001).Conclusion XBXHD has definite clinical efficacy in the treatment of AP-ALI and is worthy of further promotion and application in clinical practice.

刘礼剑;雷晓云;谢敏坚;黎丽群;李桂芳;黄明珠;谢胜

广西中医药大学第一附属医院,广西 南宁 530001广西中医药大学研究生学院,广西 南宁 530001广西中医药大学研究生学院,广西 南宁 530001广西中医药大学第一附属医院,广西 南宁 530001广西中医药大学研究生学院,广西 南宁 530001广西中医药大学研究生学院,广西 南宁 530001广西中医药大学第一附属医院,广西 南宁 530001

医药卫生

急性胰腺炎肺损伤宣痹泻黄汤真实世界研究

Acute pancreatitis lung injuryXuanbi Xiehuang Decoction(宣痹泻黄汤)Real world research

《时珍国医国药》 2026 (16)

3088-3093,6

广西青年岐黄学者培养项目(GXQH202416)广西中医药重点研究室建设项目(桂中医药科教发[2023]9号)国家中医药管理局高水平中医药重点学科建设项目(zyyzdxk-2023167)广西医疗卫生重点学科项目(桂卫科教发[2023]1号)桂派大师工作室建设项目(GZY2024004)中华中医药学会-培英计划项目

10.70976/j.1008-0805.SZGYGY-2026-1613

评论